These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36921926)

  • 1. Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management.
    Fleming B; Edison P; Kenny L
    BMJ; 2023 Mar; 380():e071726. PubMed ID: 36921926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment.
    Treanor CJ; McMenamin UC; O'Neill RF; Cardwell CR; Clarke MJ; Cantwell M; Donnelly M
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011325. PubMed ID: 27529826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.
    Lange M; Joly F; Vardy J; Ahles T; Dubois M; Tron L; Winocur G; De Ruiter MB; Castel H
    Ann Oncol; 2019 Dec; 30(12):1925-1940. PubMed ID: 31617564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy-related cognitive impairment: mechanisms, clinical features and research perspectives.
    Cascella M; Di Napoli R; Carbone D; Cuomo GF; Bimonte S; Muzio MR
    Recenti Prog Med; 2018 Nov; 109(11):523-530. PubMed ID: 30565571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cancer-related Cognitive Impairment: Current Knowledge and Future Challenges].
    Tanimukai H
    Seishin Shinkeigaku Zasshi; 2015; 117(8):585-600. PubMed ID: 26642725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-pharmacological interventions for cognitive impairment in women with breast cancer post-chemotherapy: A systematic review.
    Floyd R; Dyer AH; Kennelly SP
    J Geriatr Oncol; 2021 Mar; 12(2):173-181. PubMed ID: 32536427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular cognitive impairment: Advances and trends.
    Barbay M; Taillia H; Nedelec-Ciceri C; Arnoux A; Puy L; Wiener E; Canaple S; Lamy C; Godefroy O; Roussel M;
    Rev Neurol (Paris); 2017; 173(7-8):473-480. PubMed ID: 28838792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer, cognitive impairment, and meditation.
    Biegler KA; Chaoul MA; Cohen L
    Acta Oncol; 2009; 48(1):18-26. PubMed ID: 19031161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An overview of the research of cancer-related cognitive impairment].
    Ferencz V; S Nagy Z; Tóth M
    Orv Hetil; 2019 Sep; 160(38):1495-1502. PubMed ID: 31537098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-related cognitive impairment: does integrating complementary medicine have something to add? Review of the literature.
    Avisar A; River Y; Schiff E; Bar-Sela G; Steiner M; Ben-Arye E
    Breast Cancer Res Treat; 2012 Nov; 136(1):1-7. PubMed ID: 22915072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results.
    Cerulla N; Arcusa À; Navarro JB; de la Osa N; Garolera M; Enero C; Chico G; Fernández-Morales L
    J Clin Exp Neuropsychol; 2019 Apr; 41(3):290-299. PubMed ID: 30477390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological functioning among patients with different types of cancer : Postchemotherapy cognitive impairment and implications for rehabilitation.
    Megari K
    Neuropsychiatr; 2021 Jun; 35(2):92-97. PubMed ID: 32274652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature.
    Meattini I; Desideri I; Francolini G; Vannini A; Perna M; Garlatti P; Grassi R; Livi L
    Med Oncol; 2017 May; 34(5):74. PubMed ID: 28364269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal investigation of cognitive deficits in breast cancer patients and their gray matter correlates: impact of education level.
    Perrier J; Viard A; Levy C; Morel N; Allouache D; Noal S; Joly F; Eustache F; Giffard B
    Brain Imaging Behav; 2020 Feb; 14(1):226-241. PubMed ID: 30406352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive effects of chemotherapy: An integrative review.
    Shaw C; Baldwin A; Anderson C
    Eur J Oncol Nurs; 2021 Oct; 54():102042. PubMed ID: 34607177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Structural Model for Chemotherapy Related Cognitive Impairment and Quality of Life in Breast Cancer Patients].
    Lee JR; Oh PJ
    J Korean Acad Nurs; 2019 Aug; 49(4):375-385. PubMed ID: 31477668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Putting evidence into practice: evidence-based interventions for cancer and cancer treatment-related cognitive impairment.
    Von Ah D; Jansen C; Allen DH; Schiavone RM; Wulff J
    Clin J Oncol Nurs; 2011 Dec; 15(6):607-15. PubMed ID: 22119972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
    Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive Changes After Adjuvant Treatment in Older Adults with Early-Stage Breast Cancer.
    Lange M; Heutte N; Noal S; Rigal O; Kurtz JE; Lévy C; Allouache D; Rieux C; Lefel J; Clarisse B; Leconte A; Veyret C; Barthélémy P; Longato N; Tron L; Castel H; Eustache F; Giffard B; Joly F
    Oncologist; 2019 Jan; 24(1):62-68. PubMed ID: 29934409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.